Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

TRANSMEDICA HOLDING 2007 A/S - Group Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 8.7% 8.7%   Bankruptcy risk   3.9% 3.0% 3.0% 3.4% 0.4% 0.4% 4.4% 4.1%   Credit score (0-100)   52 58 57 53 100 100 47 49   Credit rating   BBB BBB BBB BBB AAA AAA BBB BBB   Credit limit (mDKK)   0.0 0.0 0.0 0.0 21.8 23.1 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1.0 Income statement (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   181 217 230 289 354 364 364 364   Gross profit   138 185 174 225 273 262 0.0 0.0   EBITDA   8.0 28.6 7.4 14.7 48.1 49.2 0.0 0.0   EBIT   8.0 28.6 7.4 14.7 39.0 40.1 0.0 0.0   Pre-tax profit (PTP)   -9.0 12.6 3.9 0.4 19.9 27.9 0.0 0.0   Net earnings   -9.0 12.6 3.9 0.4 11.1 18.4 0.0 0.0   Pre-tax profit without non-rec. items   8.0 28.6 7.4 14.7 19.9 27.9 0.0 0.0     See the entire income statement 1.0 Balance sheet (mDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 202 222 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 117 136 64.3 64.3   Interest-bearing liabilities   0.0 0.0 0.0 0.0 153 136 0.0 0.0   Balance sheet total (assets)   321 335 348 335 347 355 64.3 64.3   Net Debt   0.0 0.0 0.0 0.0 97.1 89.3 -25.5 -25.5     See the entire balance sheet 1.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   181 217 230 289 354 364 364 364   Net sales growth   -3.7% 19.7% 6.1% 25.3% 22.5% 2.7% 0.0% 0.0%   Gross profit   138 185 174 225 273 262 0.0 0.0   Gross profit growth   -5.8% 33.8% -5.6% 29.0% 21.5% -4.1% -100.0% 0.0%   Employees   0 0 0 0 168 175 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 4.2% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   321 335 348 335 347 355 64 64   Balance sheet change%   -8.4% 4.4% 4.0% -3.7% 3.5% 2.2% -81.9% 0.0%   Added value   8.0 28.6 7.4 14.7 39.0 49.2 0.0 0.0   Added value %   4.4% 13.2% 3.2% 5.1% 11.0% 13.5% 0.0% 0.0%   Investments   -290 0 0 0 241 2 -223 0   Net sales trend   -1.0 1.0 2.0 3.0 4.0 5.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   4.4% 13.2% 3.2% 5.1% 13.6% 13.5% 0.0% 0.0%   EBIT %   4.4% 13.2% 3.2% 5.1% 11.0% 11.0% 0.0% 0.0%   EBIT to gross profit (%)   5.8% 15.5% 4.2% 6.5% 14.3% 15.3% 0.0% 0.0%   Net Earnings %   -5.0% 5.8% 1.7% 0.1% 3.1% 5.1% 0.0% 0.0%   Profit before depreciation and extraordinary items %   -5.0% 5.8% 1.7% 0.1% 5.7% 7.6% 0.0% 0.0%   Pre tax profit less extraordinaries %   4.4% 13.2% 3.2% 5.1% 5.6% 7.7% 0.0% 0.0%   ROA %   2.4% 8.7% 2.2% 4.3% 11.5% 12.1% 0.0% 0.0%   ROI %   2.5% 8.7% 2.2% 4.3% 12.7% 15.0% 0.0% 0.0%   ROE %   -18.2% 0.0% 0.0% 0.0% 19.8% 15.2% 0.0% 0.0%   1.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 41.4% 46.5% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 62.0% 55.8% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 46.1% 42.9% -7.0% -7.0%   Net int. bear. debt to EBITDA, %   0.0% 0.0% 0.0% 0.0% 201.8% 181.7% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 131.1% 100.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 25.4% 10.2% 0.0% 0.0%   1.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.0   Current Ratio   0.0 0.0 0.0 0.0 1.9 1.9 0.0 0.0   Cash and cash equivalent   0.0 0.0 0.0 0.0 56.0 46.9 0.0 0.0   1.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 23.6 30.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 84.8 91.7 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 27.3% 25.6% 7.0% 7.0%   Net working capital   0.0 0.0 0.0 0.0 46.7 43.3 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 13.2% 11.9% 0.0% 0.0%   1.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 2 2 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0